Recommendation to include budesonide and tixocortol pivalate in the European standard series

Contact Dermatitis

Volumn 43, Issue 1, 2000, Pages 41-42

  Isaksson, M ^a   Brandao, F M ^b   Bruze, M ^a   Goossens, A ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HOSPITAL GARCIA DE ORTA   (Portugal)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Budesonide; Contact allergy; Corticosteroids; Medicaments; Patch testing technique; Standard series; Tixocortol pivalate

Indexed keywords

BUDESONIDE; CORTICOSTEROID; TIXOCORTOL PIVALATE;

CONTACT ALLERGY; DRUG CLASSIFICATION; DRUG HYPERSENSITIVITY; EUROPE; HUMAN; NOTE; PATCH TEST; SCREENING TEST; STANDARD;

ADMINISTRATION, TOPICAL; ALLERGENS; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; DERMATITIS, ALLERGIC CONTACT; EUROPE; HUMANS; HYDROCORTISONE; PATCH TESTS; PRACTICE GUIDELINES; REFERENCE STANDARDS;

EID: 0034125826     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2000.043001041.x     Document Type: Note

References (16)

1. 1. Bircher A J, Thurlimann W, Hunziker T, Pasche-Koo F, Hunziker N, Perrenoud D et al. Contact hypersensitivity to corticosteroids in routine patch test patients. A multicentre study of the Swiss Contact Dermatitis Research Group. Dermatology 1995: 191: 109-114.
2. 2. Burden A D, Beck M H. Contact hypersensitivity to topical corticosteroids. Br J Dermatol 1992: 127: 497-500.
3. 3. Lauerma A I. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone. Contact Dermatitis 1991: 24: 123-130.
4. 4. Lepoittevin I-P, Drieghe J, Dooms-Goossens A. Studies in patients with corticosteroid contact allergy. Understanding cross-reactivity among different steroids. Arch Dermatol 1995: 131: 31-37.
5. 5. Lutz M E, el-Azhary R A, Gibson L E, Fransway A F. Contact hypersensitivity to tixocortol pivalate. J Am Acad Dermatol 1998: 38: 691-695.
6. 6. Isaksson M, Anderson K E, Brandao F M, Bruynzeel D P, Bruze M, Camarasa J G, et al. Patch testing with corticosteroid mixes in Europe. Contact Dermatitis 2000: 42: in press.
7. 7. Vestergaard L, Andersen K E. Contact allergy to local steroids. Contact allergy to corticosteroids among consecutively tested patients with eczema. Ugeskr Laeger 1997: 159: 5662-5666.
8. 8. Wilkinson S M, Beck M H. Corticosteroid contact hypersensitivity: what vehicle and concentration? Contact Dermatitis 1996: 34: 305-308.
9. 9. Bruze M, Condé-Salazar L, Goossens A, Kanerva L, White I R. Thoughts on sensitizers in a standard patch test series. Contact Dermatitis 2000: 43: in press.
10. 10. Isaksson M, Bruze M, Goossens A, Lepoittevin J-P. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time. Contact Dermatitis 1999: 40: 24-31.
11. 11. Malmkvist-Padoan S, Björkner B, Bruze M, Edman B, Möller H, Svensson Å. Contact allergy to corticosteroids in Southern Sweden (abstr). 2nd Congress of the European Society of Contact Dermatitis, 8 October 1994.
12. 12. Isaksson M, Andersen K E, Brandāo F M, Bruynzeel D P, Bruze M, Diepgen T et al. Patch testing with budesonide in serial dilutions. A multicentre study of the EECDRG. Contact Dermatitis 2000: 42: in press.
13. 13. Le Coz C J, El Bakali A, Untereiner F, Grosshans E. Active sensitization to budesonide and para-phenylenediamine from patch testing. Contact Dermatitis 1998: 39: 153-155.
14. 14. Goldsmith P C, White I R, Rycroft R J G, McFadden J P. Probable active sensitization to tixocortol pivalate. Contact Dermatitis 1995: 33: 429.
15. 15. Isaksson M, Bruze M, Matura M, Goossens A. Patch testing with low concentrations of budesonide detects contact allergy. Contact Dermatitis 1997: 37: 241-242.
16. 16. Isaksson M, Gruvberger B, Persson L, Bruze M. Stability of corticosteroid patch test preparations. Contact Dermatitis 2000: 42: in press.